BFRIW
Biofrontera Inc.
Key Financials
Operating Income
$-11348000
↑ 34.1%
Revenue
$41.7M
↑ 11.7%
Net Income
$-10536000
↑ 40.7%
Total Assets
$28.6M
↑ 29.2%
EPS (Diluted)
$-1.04
↑ 67.7%
Shareholders' Equity
$10.5M
↑ 136.4%
Cash & Equivalents
$6.4M
↑ 8.2%
Total Liabilities
$18.1M
↑ 2.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| S-8 | 7/22/2026 | View on SEC |
| 10-K/A | 7/22/2026 | View on SEC |
| 8-K | 6/17/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BFRIW |
| Company Name | Biofrontera Inc. |
| CIK | 1858685 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-245-1325 |